Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled studyYu Song, Junping Shi, Wenjing Ni et al.|Cell Reports Medicine|2025Cited by 29
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Hong You, Yufeng Gao et al.|Hepatology|2025Cited by 10
Low Dose Vitamin E Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Investigator-Initiated TrialYu Song, Junping Shi, Ming‐Hua Zheng et al.|SSRN Electronic Journal|2023Cited by 0
Vitamin E (300mg) Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled StudyYu Song, Junping Shi, Ming‐Hua Zheng et al.|SSRN Electronic Journal|2024Cited by 0